Michèle J. Hoffmann

Author

Michèle J. Hoffmann

Heinrich Heine University Düsseldorf ORCID

Also Known As

Hoffmann, M., Hoffmann, Michele, Hoffmann, Michèle J., Hoffmann, Michèle Janine 1978-, M J Hoffmann, M. Hoffmann, M. J. Hoffmann, M.J. Hoffmann, MICHÈLE J. HOFFMANN, Michele Hoffmann

178

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Heinrich Heine University Düsseldorf University of Duisburg-Essen University Hospital of Bern Düsseldorf University Hospital University of Bern

About

Michèle J. Hoffmann is an author at Heinrich Heine University Düsseldorf specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	707
2	Cell Biology	12	12	482
3	Immunology	2	2	31
4	Engineering	1	1	34
5	Law	1	1	34

Michèle J. Hoffmann

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Downregulation of several fibulin genes in prostate cancer Agnes Wlazlinski, Rainer Engers, Michèle J. Hoffmann, The Prostate	2007	106
The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells Judith Heubach, Juliana Monsior, René Deenen, Molecular Cancer	2015	96
Human Embryonic Stem Cells Fail to Activate CHK1 and Commit to Apoptosis in Response to DNA Replication Stress Joëlle A. Desmarais, Michèle J. Hoffmann, Gregg Bingham, Stem Cells	2012	92
Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies Michèle J. Hoffmann, Mirko Müller, Rainer Engers, Biochemical Pharmacology ChromatinUrologyGenitourinary CancerMedicineCancer Genomics	2006	89
Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer Michèle J. Hoffmann, Rainer Engers, Andrea R. Florl, Cancer Biology & Therapy Histone ModificationsChromatinDna Methylation ChangesExpression ChangesMedicine	2007	83
Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma Sandy Fritzsche, Marc Kenzelmann, Michèle J. Hoffmann, Endocrine Related Cancer Spry GenesUrologyProstate CarcinomaGenitourinary CancerSprouty Proteins	2006	80
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine Makoto Isono, Michèle J. Hoffmann, Maria Pinkerneil, Journal of Experimental & Clinical Cancer Research	2017	79
Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines Alexander Sebastian Hölscher, Wolfgang A. Schulz, Maria Pinkerneil, Clinical Epigenetics	2018	78
Effects of novel HDAC inhibitors on urothelial carcinoma cells Aline Kaletsch, Maria Pinkerneil, Michèle J. Hoffmann, Clinical Epigenetics	2018	75
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma Valerie Wittibschlager, Ulrike Bacher, Katja Seipel, International Journal of Molecular Sciences	2023	65

Page 1